Brazil Crispr And Cas Genes Market Size & Outlook
Brazil crispr and cas genes market, 2018-2030 (US$M)
Related Markets
Brazil crispr and cas genes market highlights
- The Brazil crispr and cas genes market generated a revenue of USD 82.1 million in 2024 and is expected to reach USD 188.5 million by 2030.
- The Brazil market is expected to grow at a CAGR of 15.2% from 2025 to 2030.
- In terms of segment, product was the largest revenue generating product & service in 2024.
- Service is the most lucrative product & service segment registering the fastest growth during the forecast period.
Crispr and cas genes market data book summary
| Market revenue in 2024 | USD 82.1 million |
| Market revenue in 2030 | USD 188.5 million |
| Growth rate | 15.2% (CAGR from 2025 to 2030) |
| Largest segment | Product |
| Fastest growing segment | Service |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Product, Service |
| Key market players worldwide | AstraZeneca PLC, Caribou Biosciences Inc Ordinary Shares, Cellectis SA, CRISPR Therapeutics AG, Editas Medicine Inc, Roche Holding AG, PerkinElmer, Genscript Biotech Corp Class H, Danaher Corp, Intellia Therapeutics Inc, Lonza Group Ltd, Merck KGaA, Takara Bio Inc, Thermo Fisher Scientific Inc, Cibus Inc Ordinary Shares - Class A, Beam Therapeutics Inc, Vertex Pharmaceuticals Inc, Addgene, EGenesis, Synthego, Mammoth Biosciences, Inscripta, PLANTEDIT, Hera Biotech, Origene Technologies, Recombinetics |
Other key industry trends
- In terms of revenue, Brazil accounted for 1.8% of the global crispr and cas genes market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil crispr and cas genes market is projected to lead the regional market in terms of revenue in 2030.
- Brazil is the fastest growing regional market in Latin America and is projected to reach USD 188.5 million by 2030.
Product was the largest segment with a revenue share of 88.67% in 2024. Horizon Databook has segmented the Brazil crispr and cas genes market based on product, service covering the revenue growth of each sub-segment from 2018 to 2030.
Brazil is expected to adopt gene modification tools primarily for the production of GM crops. The country was reported to have the second-largest area under cultivation for GM crops. In June 2018, the country expanded its area dedicated to cultivating GM crops by 1.1 million hectares and yielded food products such as soy and corn.
Biotech crops, including cotton, soybean, and corn, represent about 94% of such crops in Brazil. The country is expected to witness continuous growth and developments in GM crops. This can increase the demand for CRISPR technologies in the agriculture industry, as Brazil continues to show a high preference for GM crops.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
CRISPR And Cas Genes Market Scope
CRISPR And Cas Genes Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Brazil crispr and cas genes market size, by product & service, 2018-2030 (US$M)
Brazil CRISPR And Cas Genes Market Outlook Share, 2024 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
